Clinical Trials Directory

Explore 66,650 clinical trials worldwide

Showing 37901-37950 of 66,650 trials

Active filters:Status: Recruiting

Clinical Trials (66,650)

NCT05942352
Clinical Study of Ligustrazine in Treating Alcohol Addiction
PHASE4Recruiting
400 participants
Started: Jul 28, 2023 · Completed: Jul 31, 2024
2 conditions1 sponsor1 location
NCT05956834
A Multi-Modal Remote Monitoring Platform for Frontotemporal Lobar Degeneration (FTLD) Syndromes
N/ARecruiting
60 participants
Started: Jul 28, 2023 · Completed: Dec 30, 2026
7 conditions3 sponsors2 locations
NCT05623397
A Deep Learning Method to Evaluate QT on Ribociclib
N/ARecruiting
70 participants
Started: Jul 28, 2023 · Completed: Sep 28, 2026
2 conditions1 sponsor4 locations
NCT06560801
Dapagliflozin on Renal Morphology and Renal Perfusion in Patients One Year After Kidney Transplantation
PHASE4Recruiting
48 participants
Started: Jul 28, 2023 · Completed: Dec 31, 2026
1 condition1 sponsor1 location
NCT06792435
XNW27011 Study of Advanced Solid Tumor Subjects Who Failed Standard Therapies.
PHASE1/PHASE2Recruiting
240 participants
Started: Jul 27, 2023 · Completed: Dec 31, 2025
7 conditions1 sponsor1 location
NCT06925815
Pregnancy Cohort Study: Pregnancy as a Window to Future Health
N/ARecruiting
800 participants
Started: Jul 27, 2023 · Completed: Jun 30, 2034
3 conditions1 sponsor1 location
NCT06072872
Portable Continuous Positive Airways Pressure (CPAP) in Excessive Central Airway Collapse (ECAC) Study
NARecruiting
20 participants
Started: Jul 27, 2023 · Completed: Jul 31, 2024
4 conditions1 sponsor1 location
NCT06227117
Neoadjuvant Study of DV in Combination Toripalimab or Sequence Chemotherapy in HR-negative, HER2 Low-expressing Breast Cancer
PHASE2Recruiting
120 participants
Started: Jul 27, 2023 · Completed: Dec 31, 2026
1 condition1 sponsor5 locations
NCT05036538
Decreasing Preoperative Stress to Prevent Postoperative Delirium and Postoperative Cognitive Decline in Cardiac Surgical Patients.
NARecruiting
125 participants
Started: Jul 27, 2023 · Completed: Nov 30, 2025
3 conditions1 sponsor1 location
NCT06007170
Performance of the SPIRION Laryngeal Pacemaker in BVFP Patients Without Glottal Enlargement
NARecruiting
20 participants
Started: Jul 27, 2023 · Completed: Dec 31, 2028
1 condition1 sponsor6 locations
NCT05978141
A Registry for People With T-cell Lymphoma
N/ARecruiting
1,000 participants
Started: Jul 27, 2023 · Completed: Jul 27, 2030
31 conditions1 sponsor26 locations
NCT05495906
A Study of Reduced Dosing of the Nonavalent HPV Vaccine in Women Living With HIV
PHASE4Recruiting
450 participants
Started: Jul 27, 2023 · Completed: Jan 31, 2028
3 conditions1 sponsor10 locations
NCT05638581
Trauma Resuscitation With Low-Titer Group O Whole Blood or Products
PHASE3Recruiting
1,100 participants
Started: Jul 27, 2023 · Completed: Jun 30, 2027
2 conditions3 sponsors13 locations
NCT05953155
YOga for Patients with Chronic BACK Pain and Poor PROgnosis
NARecruiting
110 participants
Started: Jul 27, 2023 · Completed: Jul 30, 2027
4 conditions1 sponsor1 location
NCT05709210
Pilot Study on the Feasibility of Using Smartphone Data as a Diagnostic Marker for Alzheimer's Disease.
NARecruiting
90 participants
Started: Jul 27, 2023 · Completed: Feb 15, 2024
2 conditions2 sponsors1 location
NCT05957848
Guanfacine Extended-release for Adolescents With Cannabis Use
PHASE2Recruiting
100 participants
Started: Jul 27, 2023 · Completed: Jun 30, 2026
1 condition3 sponsors1 location
NCT06367959
Health Benefits of Writing Therapy Among Asian American Cancer Survivors
NARecruiting
192 participants
Started: Jul 27, 2023 · Completed: Aug 31, 2026
1 condition1 sponsor1 location
NCT05978557
Brain Slice Explants to Predict Drug Response in Brain Tumors
N/ARecruiting
50 participants
Started: Jul 27, 2023 · Completed: Mar 1, 2028
1 condition1 sponsor1 location
NCT05725564
Testing Interventions for Mobility Through Exercise (TIME)
NARecruiting
620 participants
Started: Jul 27, 2023 · Completed: Sep 30, 2026
2 conditions1 sponsor1 location
NCT06680284
Toronto Western Hospital (TWH) Waste Audit
N/ARecruiting
60 participants
Started: Jul 27, 2023 · Completed: Dec 20, 2025
1 condition1 sponsor1 location
NCT05949593
Phase 3, Randomized, Placebo-Controlled Study of Tinlarebant to Explore Safety and Efficacy in Geographic Atrophy
PHASE3Recruiting
429 participants
Started: Jul 27, 2023 · Completed: Nov 30, 2027
1 condition1 sponsor49 locations
NCT05918640
Lurbinectedin in FET-Fused Tumors
PHASE1/PHASE2Recruiting
63 participants
Started: Jul 27, 2023 · Completed: Jul 30, 2028
4 conditions3 sponsors6 locations
NCT06054373
The Distribution of Immunoglobulin Isotype in Polyclonal Hypergammaglobulinemia in Systemic and Autoimmune Diseases
N/ARecruiting
150 participants
Started: Jul 27, 2023 · Completed: Sep 30, 2024
2 conditions2 sponsors1 location
NCT06324513
Evaluation of the Efficacy and Tolerability of the Mediterranean Diet Pattern in the Exclusion Diet for Patients With Crohn's Disease.
NARecruiting
120 participants
Started: Jul 27, 2023 · Completed: Oct 27, 2025
1 condition1 sponsor3 locations
NCT05608668
Inspiratory Pulmonary Rehabilitation for Children With Obesity and Asthma
NARecruiting
60 participants
Started: Jul 27, 2023 · Completed: Jun 30, 2026
2 conditions2 sponsors1 location
NCT05585281
A Study of Fluzoparib Combined With QL1101 Maintenance Treatment in Patients With Advanced Ovarian Cancer Following Response on Front-Line Platinum-Based Chemotherapy
PHASE2Recruiting
25 participants
Started: Jul 27, 2023 · Completed: Dec 22, 2025
1 condition1 sponsor1 location
NCT05391113
REward SYSTem in Autism Spectrum Disorder and Addictive Disorder
NARecruiting
78 participants
Started: Jul 27, 2023 · Completed: Jan 27, 2027
1 condition2 sponsors3 locations
NCT05998928
A Clinical Study to Evaluate the Safety and Efficacy of BCMA-GPRC5D CAR-T in Patients With Relapsed/Refractory Multiple Myeloma Who Received Three or More Lines of Therapy
PHASE2Recruiting
10 participants
Started: Jul 27, 2023 · Completed: Jul 27, 2026
1 condition2 sponsors1 location
NCT05978492
A Study of TXN10128 in Subjects With Solid Tumors
PHASE1Recruiting
96 participants
Started: Jul 27, 2023 · Completed: Jun 30, 2026
1 condition1 sponsor6 locations
NCT05778188
A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of RLS-0071 in Newborns With Moderate or Severe Hypoxic-Ischemic Encephalopathy Undergoing Therapeutic Hypothermia
PHASE2Recruiting
42 participants
Started: Jul 27, 2023 · Completed: Apr 30, 2026
1 condition2 sponsors15 locations
NCT05568550
Pembro With Radiation With or Without Olaparib
PHASE2Recruiting
64 participants
Started: Jul 27, 2023 · Completed: Jul 2, 2029
1 condition2 sponsors2 locations
NCT06171191
Move ARound And Get Active: an Intervention to Optimize 24-hour Movement Behaviours in Preschoolers
NARecruiting
200 participants
Started: Jul 27, 2023 · Completed: Dec 31, 2024
8 conditions5 sponsors4 locations
NCT05375474
Antithrombotic Strategy Based on Clinical Events and 4D-CT for Patients After TAVR
PHASE4Recruiting
650 participants
Started: Jul 27, 2023 · Completed: Dec 31, 2025
3 conditions1 sponsor1 location
NCT06090578
TabCAT Brain Health Assessment in Primary Care
NARecruiting
180,000 participants
Started: Jul 27, 2023 · Completed: Dec 31, 2026
2 conditions3 sponsors1 location
NCT05884320
Phase II Trial of Sacituzumab Govitecan in Recurrent and/or Metastatic Secretory Gland Cancers
PHASE2Recruiting
30 participants
Started: Jul 27, 2023 · Completed: Dec 31, 2026
2 conditions2 sponsors1 location
NCT05895409
A Multicenter Prospective Study of Risk Factors in Progressive Pulmonary Fibrosis
N/ARecruiting
610 participants
Started: Jul 27, 2023 · Completed: Jun 1, 2028
1 condition1 sponsor1 location
NCT05934331
A LM-302 Combination With Other Anti-Tumor Therapies Phase ll Study
PHASE2Recruiting
276 participants
Started: Jul 27, 2023 · Completed: Jul 1, 2028
1 condition1 sponsor1 location
NCT05777278
Savolitinib Plus Docetaxel as 2L in EGFR/ALK/ROS1/MET ex14m-wildtype NSCLC With MET Overexpression
PHASE1/PHASE2Recruiting
29 participants
Started: Jul 26, 2023 · Completed: Aug 31, 2027
1 condition1 sponsor1 location
NCT05924256
A Phase II Study of Advanced Salivary Gland Carcinoma Based on Molecular Typing
PHASE2Recruiting
88 participants
Started: Jul 26, 2023 · Completed: Dec 30, 2026
1 condition1 sponsor1 location
NCT05895825
A Study of EOC237 in Patients With Advanced Solid Tumor
PHASE1Recruiting
48 participants
Started: Jul 26, 2023 · Completed: Sep 30, 2026
1 condition1 sponsor1 location
NCT06204484
MRD-guided Deferred Adjuvant Therapy in Resectable Early-stage Colon Cancer
NARecruiting
349 participants
Started: Jul 26, 2023 · Completed: Jul 31, 2028
1 condition2 sponsors1 location
NCT06193057
Comparison of Customized and Standard Total Ankle Prostheses
NARecruiting
24 participants
Started: Jul 26, 2023 · Completed: Jul 26, 2026
1 condition1 sponsor1 location
NCT05982561
Clinical Evaluation of BCDx for Monitoring of Recurrence in Non-Muscle Invasive Bladder Cancer
N/ARecruiting
500 participants
Started: Jul 26, 2023 · Completed: Dec 31, 2025
1 condition1 sponsor3 locations
NCT05878730
Melatonin and Response to Lithium
N/ARecruiting
60 participants
Started: Jul 26, 2023 · Completed: Jul 31, 2026
1 condition1 sponsor1 location
NCT05919290
HN-QUEST: A Study of Head and Neck Imaging Biomarkers
NARecruiting
173 participants
Started: Jul 26, 2023 · Completed: Jul 1, 2029
1 condition1 sponsor1 location
NCT05949541
Efficacy of Everolimus Combined With First-line Endocrine Therapy for HR+/HER2- SNF1-subtype Advanced Breast Cancer
PHASE2Recruiting
265 participants
Started: Jul 26, 2023 · Completed: Jan 31, 2028
2 conditions1 sponsor1 location
NCT05935735
Feasibility of Brief Behavioral Therapy for Insomnia (BBTI) in SUD Recovery
NARecruiting
150 participants
Started: Jul 26, 2023 · Completed: Dec 31, 2026
2 conditions2 sponsors1 location
NCT05612178
A Study to Evaluate the Safety and Effects of Repeated Doses of 3BNC117-LS and 10-1074-LS on Persistent Viral Reservoirs in People Living With HIV and on Suppressive Antiretroviral Therapy
PHASE1Recruiting
200 participants
Started: Jul 26, 2023 · Completed: Dec 31, 2025
1 condition1 sponsor2 locations
NCT05301348
In Vivo Detection of Circulating Clots in Patients With Thromboembolism
NARecruiting
30 participants
Started: Jul 26, 2023 · Completed: Jan 31, 2026
1 condition1 sponsor1 location
NCT05918692
A Phase 1, Study of BMF-500 in Adults With Acute Leukemia
PHASE1Recruiting
84 participants
Started: Jul 26, 2023 · Completed: Dec 31, 2025
1 condition1 sponsor23 locations